Update on FIRB condition and scheme
Filed with ASX · · 1 page · English
Watch Mayne Pharma's latest callMayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call · Replay · Aug 26Read the transcript of Mayne Pharma Group (ASX:MYX) Q4 2026 Earnings Call21 November 2025, Adelaide, Australia: Mayne Pharma Group Limited (ASX: MYX) (Mayne Pharma) refers to its proposed acquisition by Cosette Pharmaceuticals, Inc. (Cosette) by way of scheme of arrangement (Scheme). Mayne Pharma was notified by Cosette shortly after market open this morning that it had received written notice from the Foreign Investment Review Board (FIRB) stating that the Treasurer h
Mayne Pharma Group Ltd. on 6ix
Story so far
Earlier from Mayne Pharma
- Trading Halt
- Pause in Trading
- Update on status of FIRB approval and second court hearing
- MYX Declaration of Unacceptable Circumstances and Orders
- Update on FIRB approval and Scheme
Later from Mayne Pharma
- Mayne Pharma issues notice of intention to terminate the SID
- MYX receives purported termination notice from Cosette
- Mayne Pharma terminates Scheme Implementation Deed
- Termination of Proposed Acquisition of Mayne Pharma
- Market Update
Follow Mayne Pharma into a list and get an email when it puts out news.
Follow Mayne Pharma